Advancing Non-Invasive Prenatal Testing at the 32nd International Congress of the Obstetrical and Gynaecological Society of Malaysia (OGSM) 2025
Advancing Non-Invasive Prenatal Testing at the 32nd International Congress of the Obstetrical and Gynaecological Society of Malaysia (OGSM) 2025. Gene Solutions Malaysia was pleased to participate in the 32nd International Congress of OGSM, held from 11–13 July 2025 in Penang, Malaysia. Established in 1963, OGSM now has over 1,600 active members. At this 32nd International […]
The Past, Present, and Future of ctDNA-Monitoring in Cancer Care
The Best of ASCO Hong Kong 2025, held on July 5, 2025, showcased practice changing clinical data from the ASCO 2025 Annual Meeting. Licensed by ASCO and organized by the Hong Kong International Oncology Research Society in collaboration with ASCO, this one-day event brought together oncology experts to explore advancements in cancer care. With a […]
New Study Shows High-Precision ctDNA Monitoring Predicts Early Breast Cancer Recurrence
The latest data from Gene Solutions demonstrates the clinical value of personalized ctDNA monitoring with the K-TRACK™ platform A prospective study recently published in npj Breast Cancer provides compelling data on the prognostic value of circulating tumor DNA (ctDNA) in early-stage breast cancer. Conducted by Gene Solutions in collaboration with leading Vietnamese cancer centers, the […]
Gene Solutions at ESMO TAT Asia 2025
Innovation and collaboration defined ESMO TAT Asia 2025. ESMO TAT’s first event in Asia attracted over 600 oncologists and healthcare professionals from 16 countries and territories. 🔬 Gene Solutions, in collaboration with the Medical Genetics Institute Vietnam, was proud to promote 11 innovative and promising studies at ESMO TAT Asia 2025 – selected from among 66 […]
Gene Solutions Presents 11 Posters at ESMO TAT Asia 2025: Advancing the Future of Precision Oncology
Gene Solutions is proud to participate in ESMO TAT Asia 2025, held in Hong Kong from July 18–20. At this prestigious event, we will host an interactive booth and present 11 cutting-edge posters, covering novel approaches in neoantigen discovery, AI-powered immunotherapy design, genomic & transcriptomic profiling, circulating tumor DNA (ctDNA) monitoring, and organoid-based drug development. […]
GENE SOLUTIONS WELCOMES KENG HSU AS NEW CHIEF FINANCIAL OFFICER
Singapore, 1st Jul 2025 – Gene Solutions, a leading biotech innovator in precision medicine and genetic testing, is pleased to announce the appointment of Keng Hsu as our new Chief Financial Officer (CFO). This strategic addition reflects the company’s continued focus on scaling its operations globally and strengthening its financial leadership amid rapid growth across […]
Asia’s First Large-Scale Validated Multi-Cancer Test to Transform Early Detection in China
The 3rd Guangdong Cancer Screening and Early Diagnosis and Treatment Conference, held on June 20–21, 2025, highlighted transformative advancements in early cancer detection. Co-hosted by the Guangdong Cancer Center, the Guangdong Anti-Cancer Association’s Committee of Early Cancer Diagnosis and Treatment, and the Cancer Hospital Chinese Academy of Medical Sciences Shenzhen Center, with support from ZaoDx, […]
Gene Solutions Strengthens China Footprint with Strategic Partnerships in Precision Oncology
BEIJING, June 20, 2025 — Gene Solutions announces the signing of two strategic Memoranda of Understanding (MOUs) with ZaoDx and Xiong’an MagicBiotech Co., Ltd. These partnerships mark a focused expansion of Gene Solutions’ precision oncology efforts into the Chinese market through collaborative technology introduction, research exploration, and localized deployment of its innovative cancer testing platforms. Together, the […]
Gene Solutions and Shenzhen USK Bioscience Forge Strategic Partnership to Establish Next-Generation Sequencing Laboratory in Southern China
SINGAPORE, June 13, 2025 – Gene Solutions, a leading multinational biotechnology company and Shenzhen USK Bioscience Co., Ltd. (USKBio), a prominent innovator in molecular diagnostics, have entered a strategic partnership through a Memorandum of Understanding (MOU). The landmark agreement paves the way for the establishment of a state-of-the-art next generation sequencing (NGS) laboratory in southern China, […]
Gene Solutions and Topgen Join Forces to Advance Precision Oncology All Over China
SHANGHAI, June 12, 2025 — Gene Solutions has formalized a strategic collaboration with Zhejiang Shaoxing Topgen Biomedical Technology Co., Ltd., a CAP-accredited laboratory with a well-established footprint across all over China. Topgen currently operates a comprehensive next-generation sequencing (NGS) platform and serves a vast clinical network of over 1,300 hospitals. Through this collaboration, Gene Solutions will introduce several of its most advanced oncology solutions to complement and expand Topgen’s […]